Opinions expressed by MPPG Contributors are their own
Opinions expressed by MPPG Contributors are their own
Human Papilloma Virus infections caused more head and neck cancers in men than in women according to a report in the Annals of Internal Medicine. Adults participated in the National Health and Nutritional Survey from 2011 to 2014. The information was then evaluated by researchers
A state of emergency was declared on October 13th by California’s Governor, Jerry Brown due to the 18 deaths and 576 cases caused by the hepatitis A outbreak. This declaration will give the state of California the ability to purchase hepatitis A vaccine from the manufactures.
Although efficacy hasn’t been proven yet in Ebola vaccines, the immunogenicity trials show safety and promise. The findings comparing two investigational vaccine formulations to a saline placebo are reported in The New England Journal of Medicine.
This study showed impressive data on the effective protection of the PCV13 vaccine for pneumonia. Tamara Pilishvili et al evaluated incidence rates before and after the introduction and recommendation of the 13-valent pneumococcal conjugate Vaccine.
“Vaccines don’t cause autism. Vaccines, instead, prevent disease. Vaccines have wiped out a score of formerly deadly childhood diseases. Vaccine skepticism has helped to bring some of those diseases back from near extinction.”
Clinical Infectious Diseases published today a new CDC Study that demonstrated promising pertussis prevention in babies when given to their mothers during pregnancy. Nancy Messonier, MD the CDC’s director of the National Center for Immunization and Respiratory Diseases, stated “Women have such a great opportunity to help protect their babies before they enter the world by getting the Tdap vaccine while pregnant…..This study highlights how babies can benefit when their mothers get the vaccine and reinforces CDC’s recommendation for women to get Tdap vaccine in the third trimester of each pregnancy.”
This article written by Dr. H. Cody Meissner, MD FAAP and published in AAPNews is an interesting description of the additional components included in vaccines and why. From adjuvants to preservatives and stabilizers Dr. Meissner discusses the rationale and safety of each one.
AAP published new guidelines to help prevent contagious infections in organized sports. These preventative interventions help minimize the risk of outbreaks. Skin to skin contact sports and shared equipment are areas of focus for improved defensive measures.
“The thing is I think vaccines are one of the greatest medical breakthroughs that we have. I’m a big fan and a great fan of the history of the development of the smallpox vaccine, for example.”
– Rand Paul
The potential risks and complications of tattooing, piercing and scarification should be shared with teens. The AAP’s clinical report on the subject will be published in the October issue of Pediatrics. The subject ought to be addressed since tattoos are more common than in years past and it isn’t only at risk youth engaging in these alterations. Adolescents need to be aware of the potential consequences of body modification.
“There is no satisfactory substitute for excellence”
Arnold O. Beckman
In the U.S. the ACIP has not recommended the intranasal influenza vaccine, LAIV Flumist for the second season in a row. This was unfortunate news for patients averse to injections. Although this information was announced by the CDC back in June, what is of interest currently is the fact Flumist performed well in UK, Canada and Finland. Experts are analyzing why there’s a discrepancy. Read more
In a study published earlier this week The Lancet reported a 97.4% efficacy for Gardasil 9. HPV types covered are 6, 11, 16, 18, 31, 33, 45, 52 and 58. Data was collected from a large double blind study in 18 countries.
MedImmune’s FluMist wasn’t recommended for last year’s flu immunization season and it’s not recommended again for this current season, 2017-1018. The AAP has this season’s recommendations published in Pediatrics. It is of interest to note they do not state a preference for the quadrivalent over the trivalent vaccine or vise versa.
Back in April 2017, Medical Practice Purchasing Group (MPPG) and Circassia Pharmaceuticals have entered into a purchasing agreement to provide NIOX VERO® device refill test kits at a contracted price.
This agreement provides a flat-rate price per test on sensor refills for all members of MPPG, which allows each facility site to reorder test kits based on their unique needs and volume of patients. NIOX VERO® is suitable for children, approximately 7-17 years, and adults 18 years and older. The pricing is based on anticipated volume purchases of FeNO by NIOX® by the membership of MPPG. (more…)
The study published in Pediatrics this week was a meta-analysis assessing the risk of repeat adverse events in children who had a reaction following routine vaccination. They found that re-immunization is usually safe.
Yesterday Sanofi announced that the acquisition of biotech firm Protein Sciences has been completed. Sanofi Pasteur has a broad influenza vaccine portfolio and now has an even broader one with the addition of Flublok. Flublok is the only recombinant protein based influenza vaccine approved by the FDA. This is a non egg based influenza vaccine and an opportunity to research these manufacturing technologies. Read more.
According to the CDC, over 50,000 adults die each year due to vaccine preventable diseases. See these ideas from the AMA, on protecting more patients against these vaccine preventable diseases. Their program is a team based approach and is free.
“When I approach a child, he inspires in me two sentiments; tenderness for what he is, and respect for what he may become.”
– Louis Pasteur
Meta-analysis posted in CIDRAP, Center for Infectious Disease Research and Policy on protection of repeated influenza vaccine from season to season. Good news for influenza immunization.